<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://nopr.niscpr.res.in/handle/123456789/59970">
    <title>NOPR Collection:</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/59970</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://nopr.niscpr.res.in/handle/123456789/59977" />
        <rdf:li rdf:resource="http://nopr.niscpr.res.in/handle/123456789/59976" />
        <rdf:li rdf:resource="http://nopr.niscpr.res.in/handle/123456789/59975" />
        <rdf:li rdf:resource="http://nopr.niscpr.res.in/handle/123456789/59974" />
      </rdf:Seq>
    </items>
    <dc:date>2026-10-10T09:34:03Z</dc:date>
  </channel>
  <item rdf:about="http://nopr.niscpr.res.in/handle/123456789/59977">
    <title>Removing the Roadblocks in Equitable Global Access to COVID-19 Vaccine through IPR Waiver</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/59977</link>
    <description>Title: Removing the Roadblocks in Equitable Global Access to COVID-19 Vaccine through IPR Waiver
Authors: Dahiya, Saurabh; Sharma, Chanchal; Goyal, Yachika
Abstract: In October 2020, South Africa and India proposed a plan to protect developing nations' interests and ensure a seamless&#xD;
supply of COVID-19 vaccinations. While rich countries have made rapid progress with their immunization programmes,&#xD;
many poor and underdeveloped countries have been left behind to fend for themselves due to patent protection. With the&#xD;
frightening rate at which COVID-19 cases have been emerging, the global population requires immediate and equitable&#xD;
access to life-saving vaccines. In this paper a methodological systematic review of IPR waiver related journal papers and&#xD;
newsletters published from 2019-2021 was performed. Search was conducted through significant scientific databases for&#xD;
relevant publications for this systematic review. This paper discusses to waive IPR in the COVID-19 pandemic, which has&#xD;
received both criticism and praise. Some opponents oppose the IPR waiver because it eliminates rewards for pharmaceutical&#xD;
corporations' R &amp; D efforts. Vaccine development necessitates specialized requirements which cost a lot of money. Along&#xD;
with this, pharmaceutical corporations will be hesitant to take the lead in the future if a situation similar to COVID-19 arises.&#xD;
However, those in favour believe that an IPR waiver can reduce the barriers to countries producing their own vaccines,&#xD;
particularly for the lowest-income nations. Whether the reasoning is correct or incorrect, the timely &amp; equitable distribution&#xD;
of COVID-19 immunizations is critical to the abolition of this pandemic.
Page(s): 163-170</description>
    <dc:date>2022-05-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://nopr.niscpr.res.in/handle/123456789/59976">
    <title>Protection of Cuisine under Intellectual Property Law: A Global Perspective</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/59976</link>
    <description>Title: Protection of Cuisine under Intellectual Property Law: A Global Perspective
Authors: Ghose, Anuttama; Ali, S M Aamir
Abstract: We have observed for a very long time that, in various instances, food and recipes are considered the subject matter of&#xD;
art. Different chefs and restaurants have received global recognition for their creativity and talent. Their creation forms an&#xD;
integral part of intellectual assets, which are exploited commercially. Although in popular opinion, the culinary industry is&#xD;
often considered a representation of derivative art, however, with the advancement of culinary techniques and creativity of&#xD;
chefs across the world, various forms of intellectual property laws are claimed by these proprietors and stakeholders in order&#xD;
to protect their unique creations from encroachment. Signature dishes and the unique ambiance of a restaurant are always&#xD;
the subject matter of well-known controversies. In this article, the author makes an attempt to analyze various culinary&#xD;
conflicts observed across the world and examines the various possibilities of protecting the artistic arrangement or plating of&#xD;
their dishes under traditional as well as the non-traditional scope of intellectual property laws. The article discusses the&#xD;
statutory and judicial pronouncements pertinent to this issue in the light of notable principles of Copyright, Trademark,&#xD;
Trade Secret, and Patent laws, along with ramifications involved in safeguarding the same. The findings and suggestions&#xD;
provided in this research, in the end, put forward the efficacy of confidential agreements and the requirement of strict&#xD;
statutory provisions on trade secret laws to protect the unique creation of culinary industries.
Page(s): 171-180</description>
    <dc:date>2022-05-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://nopr.niscpr.res.in/handle/123456789/59975">
    <title>How Can Lower-Income Countries Access COVID-19 Medicines Without Destroying the Patent System? The National Exhaustion Solution</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/59975</link>
    <description>Title: How Can Lower-Income Countries Access COVID-19 Medicines Without Destroying the Patent System? The National Exhaustion Solution
Authors: Eldakak, Ahmed
Abstract: Many scholars argued that improving access to medicine requires major amendments to the patent system, which is&#xD;
structured according to the Agreement on Trade-Related Aspects of Intellectual Property Rights. This article argues that the&#xD;
argument is not necessarily true. Amending Article 6 of the TRIPS Agreement to adopt a national exhaustion rule for&#xD;
pharmaceutical patents would be sufficient to achieve a considerable improvement in access to medicine while simultaneously&#xD;
strengthening patent protection. This proposal encourages the pharmaceutical industry to adopt a price discrimination policy&#xD;
whereby Pharma would lower medicine prices in the lower-income countries. Accordingly, global access to new medicines&#xD;
such as COVID-19 medicines could be increased as these countries have the majority of poor people. At the same time, Pharma&#xD;
can continue to sell the same medicine in higher-income countries at higher prices, generating sufficient profits to incentivize&#xD;
research and development.
Page(s): 181-189</description>
    <dc:date>2022-05-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://nopr.niscpr.res.in/handle/123456789/59974">
    <title>Regulatory Control on Medical Devices - A Case Study on Device Recalls by USFDA</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/59974</link>
    <description>Title: Regulatory Control on Medical Devices - A Case Study on Device Recalls by USFDA
Authors: Kamisetti, Raja Rajeswari
Abstract: The aim of the case study is to reflect on the FDA regulations on the Medical Devices, aspects of classifying the risk&#xD;
caused by the devices and to study the process of recalls by the companies strategically followed by the regulatory authority.&#xD;
Further, a case study was performed to identify the medical devices that were recalled in the year 2020, to investigate the&#xD;
reason for the recall, the subsequent effects on the system and further actions to rectify the problems. The study emphasized&#xD;
various reasons for the medical devices recalled during the year 2020. It warns the companies and users to follow the&#xD;
conditions strictly during their manufacture and trials which would minimize the errors of the functioning of the medical&#xD;
devices in the mere future. Also the study alerts the medical practitioners about the precautions and safe instructions to be&#xD;
followed during the installation and utilization of the devices.
Page(s): 190-201</description>
    <dc:date>2022-05-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

